Effect of the Glutamate NMDA Receptor Antagonist Memantine as Adjunctive Treatment in Borderline Personality Disorder: An Exploratory, Randomised, Double-Blind, Placebo-Controlled Trial.
published in: CNS Drugs
date of publication: 2018-02-01
main subject: borderline personality disorder, placebo
Cites articles 38
- 2011-01-01
- 2009-12-01
- 2008-03-01
Date
Title
Article - wd:Q52352151